Hexavest’s Halozyme HALO Stock Holding History

Hexavest’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,680	Closed	-$440K	–	258
2021 Q2	$440K	Hold	9,680	–	–	0.02%	220
2021 Q1	$404K	Sell	9,680 -8,078	-45%	-$369K	0.02%	229
2020 Q4	$758K	Buy	+17,758	New	+$638K	0.03%	191

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hexavest's HALO Position: Q3 2021 in Review

Hexavest sold out of Halozyme (HALO) in Q3 2021, closing a stake of 9,680 shares — an estimated $440K sold.

Hexavest first reported a position in HALO in Q4 2020 and held it in 3 quarters. The position peaked at $758K in Q4 2020. 325 funds tracked by Wall St. Rank hold HALO as of Q3 2021.

Hexavest reported no remaining Halozyme position as of Q3 2021 after selling out during the quarter.
Hexavest sold 9,680 Halozyme shares in Q3 2021, an estimated $440K.
Hexavest first reported a position in Halozyme in Q4 2020 and held it in 3 quarters.
Hexavest's Halozyme position peaked at $758K in Q4 2020.
325 funds tracked by Wall St. Rank held Halozyme as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.